Global Rare Hematology Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Rare Hematology Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Recombinant Factors
  • 1.4.3 Plasma Derived Factors
• 1.5 Market by Application
  • 1.5.1 Global Rare Hematology Market Share by Application (2014-2025)
  • 1.5.2 Pediatric
  • 1.5.3 Adult
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Rare Hematology Market Size
• 2.2 Rare Hematology Growth Trends by Regions
  • 2.2.1 Rare Hematology Market Size by Regions (2014-2025)
  • 2.2.2 Rare Hematology Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Rare Hematology Market Size by Manufacturers
  • 3.1.1 Global Rare Hematology Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Rare Hematology Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Rare Hematology Market Concentration Ratio (CR5 and HHI)
• 3.2 Rare Hematology Key Players Head office and Area Served
• 3.3 Key Players Rare Hematology Product/Solution/Service
• 3.4 Date of Enter into Rare Hematology Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Rare Hematology Market Size by Type (2014-2019)
• 4.2 Global Rare Hematology Market Size by Application (2014-2019)

5 United States

• 5.1 United States Rare Hematology Market Size (2014-2019)
• 5.2 Rare Hematology Key Players in United States
• 5.3 United States Rare Hematology Market Size by Type
• 5.4 United States Rare Hematology Market Size by Application

6 Europe

• 6.1 Europe Rare Hematology Market Size (2014-2019)
• 6.2 Rare Hematology Key Players in Europe
• 6.3 Europe Rare Hematology Market Size by Type
• 6.4 Europe Rare Hematology Market Size by Application

7 China

• 7.1 China Rare Hematology Market Size (2014-2019)
• 7.2 Rare Hematology Key Players in China
• 7.3 China Rare Hematology Market Size by Type
• 7.4 China Rare Hematology Market Size by Application

8 Japan

• 8.1 Japan Rare Hematology Market Size (2014-2019)
• 8.2 Rare Hematology Key Players in Japan
• 8.3 Japan Rare Hematology Market Size by Type
• 8.4 Japan Rare Hematology Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Rare Hematology Market Size (2014-2019)
• 9.2 Rare Hematology Key Players in Southeast Asia
• 9.3 Southeast Asia Rare Hematology Market Size by Type
• 9.4 Southeast Asia Rare Hematology Market Size by Application

10 India

• 10.1 India Rare Hematology Market Size (2014-2019)
• 10.2 Rare Hematology Key Players in India
• 10.3 India Rare Hematology Market Size by Type
• 10.4 India Rare Hematology Market Size by Application

11 Central & South America

• 11.1 Central & South America Rare Hematology Market Size (2014-2019)
• 11.2 Rare Hematology Key Players in Central & South America
• 11.3 Central & South America Rare Hematology Market Size by Type
• 11.4 Central & South America Rare Hematology Market Size by Application

12 International Players Profiles

• 12.1 Shire plc
  • 12.1.1 Shire plc Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Rare Hematology Introduction
  • 12.1.4 Shire plc Revenue in Rare Hematology Business (2014-2019)
  • 12.1.5 Shire plc Recent Development
• 12.2 Novo Nordisk A/S
  • 12.2.1 Novo Nordisk A/S Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Rare Hematology Introduction
  • 12.2.4 Novo Nordisk A/S Revenue in Rare Hematology Business (2014-2019)
  • 12.2.5 Novo Nordisk A/S Recent Development
• 12.3 Pfizer Inc.
  • 12.3.1 Pfizer Inc. Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Rare Hematology Introduction
  • 12.3.4 Pfizer Inc. Revenue in Rare Hematology Business (2014-2019)
  • 12.3.5 Pfizer Inc. Recent Development
• 12.4 Bayer Healthcare AG
  • 12.4.1 Bayer Healthcare AG Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Rare Hematology Introduction
  • 12.4.4 Bayer Healthcare AG Revenue in Rare Hematology Business (2014-2019)
  • 12.4.5 Bayer Healthcare AG Recent Development
• 12.5 CSL Behring LLC
  • 12.5.1 CSL Behring LLC Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Rare Hematology Introduction
  • 12.5.4 CSL Behring LLC Revenue in Rare Hematology Business (2014-2019)
  • 12.5.5 CSL Behring LLC Recent Development
• 12.6 Biogen Inc.
  • 12.6.1 Biogen Inc. Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Rare Hematology Introduction
  • 12.6.4 Biogen Inc. Revenue in Rare Hematology Business (2014-2019)
  • 12.6.5 Biogen Inc. Recent Development
• 12.7 Alexion Pharmaceuticals, Inc.
  • 12.7.1 Alexion Pharmaceuticals, Inc. Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Rare Hematology Introduction
  • 12.7.4 Alexion Pharmaceuticals, Inc. Revenue in Rare Hematology Business (2014-2019)
  • 12.7.5 Alexion Pharmaceuticals, Inc. Recent Development
• 12.8 Celgene Corporation
  • 12.8.1 Celgene Corporation Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Rare Hematology Introduction
  • 12.8.4 Celgene Corporation Revenue in Rare Hematology Business (2014-2019)
  • 12.8.5 Celgene Corporation Recent Development
• 12.9 Amgen Inc.
  • 12.9.1 Amgen Inc. Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Rare Hematology Introduction
  • 12.9.4 Amgen Inc. Revenue in Rare Hematology Business (2014-2019)
  • 12.9.5 Amgen Inc. Recent Development
• 12.10 PRA Health Sciences
  • 12.10.1 PRA Health Sciences Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Rare Hematology Introduction
  • 12.10.4 PRA Health Sciences Revenue in Rare Hematology Business (2014-2019)
  • 12.10.5 PRA Health Sciences Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer